Overview
Ribosome biogenesis is observed to be robustly upregulated in Acute myeloid leukemia compared with healthy hematopoietic cells. We focus on one of the most upregulated factors that is required for AML cell proliferation and survival in vitro and vivo. This highlights a potential therapeutic vulnerability in leukemia.